Glenmark Pharmaceuticals Limited
NSE: GLENMARK · Healthcare
₹2,400.00
+9.30 (+0.39%)
Last close · 30 Aug 2026, 11:55 am IST
- Open
- ₹2,391.70
- Day high
- ₹2,421.00
- Day low
- ₹2,376.00
- Volume
- 6.53 L
- Prev close
- ₹2,390.70
HealthcareDrug Manufacturers - Specialty & GenericPart of:All NSE StocksNifty 200Nifty 500Nifty HealthcareNifty Midcap 100Nifty Midcap 150Nifty MidSmallcap 400Nifty Pharma
Price chart
Range
EMA
Also show
Fundamentals
Drug Manufacturers - Specialty & Generic
Valuation
- Market Cap
- 65,078 Cr
- Price
- 2,305.90
- P/E (TTM)
- 36.18
- P/E (Fwd)
- 23.61
- P/B
- 6.19
- EV/EBITDA
- 13.26
- EV/Revenue
- 3.61
- PEG
- —
- Div Yield
- 0.33%
- 52W High
- 2,474.00
- 52W Low
- 1,792.60
- Beta
- 0.25
Profitability & income
- Revenue (TTM)
- 17,737 Cr
- Net Income (TTM)
- 1,798 Cr
- EBITDA
- 4,832 Cr
- Gross Margin
- 71.94%
- Op. Margin
- 15.72%
- Net Margin
- 10.14%
- ROE
- 12.96%
- ROA
- 6.84%
- EPS (TTM)
- 63.73
- EPS (Fwd)
- 97.67
Financial health
- Total Debt
- 594 Cr
- Total Cash
- 1,176 Cr
- Debt/Equity
- 5.65
- Current Ratio
- —
- Quick Ratio
- —
- Book Value
- 372.48
- Free Cash Flow
- 2,087 Cr
- Op. Cash Flow
- 3,445 Cr
Growth
- Revenue Growth
- 23.10%
- Earnings Growth
- 930.70%
- Earnings QoQ
- 930.30%
Quarterly results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 3,932 Cr | 483 Cr | 871 Cr | 632 Cr | 2,686 Cr | — | — | — |
| 2026-03-31 | 3,760 Cr | 301 Cr | 578 Cr | 615 Cr | 2,588 Cr | — | 594 Cr | 10,512 Cr |
| 2025-12-31 | 3,888 Cr | 403 Cr | 730 Cr | 715 Cr | 2,593 Cr | — | — | — |
| 2025-09-30 | 6,004 Cr | 610 Cr | 1,175 Cr | 2,218 Cr | 4,739 Cr | — | 1,224 Cr | 9,582 Cr |
| 2025-06-30 | 3,059 Cr | 47 Cr | 284 Cr | 451 Cr | 2,044 Cr | — | — | — |
| 2025-03-31 | — | — | — | — | — | — | 2,473 Cr | 8,849 Cr |
Annual results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 16,711 Cr | 1,362 Cr | 2,767 Cr | 3,999 Cr | 11,964 Cr | 3,445 Cr | 594 Cr | 10,512 Cr |
| 2025-03-31 | 13,146 Cr | 1,047 Cr | 2,092 Cr | 1,865 Cr | 8,792 Cr | -828 Cr | 2,473 Cr | 8,849 Cr |
| 2024-03-31 | 11,635 Cr | -1,502 Cr | 1,183 Cr | 631 Cr | 6,756 Cr | -265 Cr | 1,231 Cr | 7,848 Cr |
| 2023-03-31 | 11,432 Cr | 297 Cr | 1,200 Cr | 1,079 Cr | 6,845 Cr | 625 Cr | 4,608 Cr | 9,474 Cr |
| 2022-03-31 | — | — | — | — | — | — | — | — |
Figures in ₹ crore unless stated. Ratios and margins are trailing twelve months where marked TTM.
Want charts and signals for GLENMARK?
Sign in for candlestick charts with Supertrend, MACD and VWAP overlays, plus watchlists and email alerts.
Sign in